home / stock / acog:cc / acog:cc news

ACOG:CC News and Press, Alpha Cognition Inc. From 12/07/23

Stock Information
Company Name: Alpha Cognition Inc.
Stock Symbol: ACOG:CC
Market: TSXVC
Website: alphacognition.com
Menu
ACOG:CC ACOG:CC Quote ACOG:CC Short ACOG:CC News ACOG:CC Articles ACOG:CC Message Board
Get ACOG:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
ACOG:CC - Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's Disease

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that the U.S. Food and Drug Administration (FDA) ...
ACOG:CC - Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering

Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“ Alpha Cognition ” or the “ Company ”) announces that it has amended the terms of its previously announced private placement offering of up to US$6.5 million of units at a price of US$0.22 per unit. Each unit wil...

ACOG:CC - Alpha Cognition Announces Third Quarter and Nine Months Ended September 30, 2023, Results and Provides Corporate Update

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today reporte...

ACOG:CC - Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering

Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“ Alpha Cognition ” or the “ Company ”) announces that it has completed a third closing pursuant to its previously announced private placement of units of the Company. Pursuant to the third closing, the Company is...
ACOG:CC - Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering

Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“ Alpha Cognition ” or the “ Company ”) announces that it has completed a second closing pursuant to its previously announced private placement of units of the Company. Pursuant to the second closing, the Company ...

ACOG:CC - Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer's Disease

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce the submission of a New Drug Application (“...

ACOG:CC - Alpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the Offering

Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”) announces the closing of its previously announced private placement of units of the Company for gross proceeds of US$1,345,093 before deducting the placement agent’s fees and ot...
ACOG:CC - Alpha Cognition Announces Second Quarter and Six Months Ended 2023 Results and Provides Corporate Update

Not for distribution in the U.S. or to U.S. newswire services. Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the l...

ACOG:CC - Alpha Cognition Receives Notice of Allowance for U.S. Patent Application covering use of ALPHA-1062 for Mild to Moderate Alzheimer's Disease

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announced the United States Patent and Trademark Office ...

ACOG:CC - Life Science Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, June 23, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from Life Science Investor Forum, held on June 22 nd are now available for online viewing. REGISTER NOW AT : https://...
Previous 10 Next 10